Additionally, Kaplan–Meier survival analyses conducted on three distinct datasets, including TCGA pan‐glioma, CGGA325 and CGGA693, further indicate that high expression of SLC43A3 is an adverse prognostic factor (Figure 11B–D). The gene discussed is SLC43A3; the disease is central nervous system cancer.